micronavigation ELN path item Leukemias path item CMPD path item Study Groups  · 
Workpackage 9

Study Groups of Project 9: Chronic myeloproliferative diseases (CMPD)

Created by: Reiter (Project 9) , generated 2006/05/04, last changed: 2006/05/10

Name of the study group

European LeukemiaNet Eosinophilia Study Group

Disease(s)

Eosinophilia associated chronic myeloproliferative disorders (e. g. idiopathic hypereosinophilic syndrome, chronic eosinophilic leukemia, atypical chronic myeloid leukemia with eosinophilia, systemic mastocytosis with eosinophilia)

Leader(s) of the study group

Prof. J. Apperley
Imperial College School of Medicine
Hammersmith Hospital London, UK
j.apperley@ic.ac.uk

Prof. G. Martinelli
Institute of Hematology and Medical Oncology "L. and A. Seràgnoli. University of Bologna, Via Massarenti, 9-40138 Bologna, Italy. gmartino@kaiser.alma.unibo.it

Dr. A. Reiter
III. Medizinische Universitätsklinik, Klinikum Mannheim der Universität Heidelberg, Wiesbadener Str. 7-11, 68305 Mannheim. Germany
andreas.reiter@med3.ma.uni-heidelberg.de

Prof. N. C. P. Cross
Wessex Regional Genetics Laboratories, Salisbury, U.K. & Human Genetics Research Division, University of Southampton School of Medicine, Southampton, UK
ncpc@soton.ac.uk

Prof. Saglio
Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, 10043 Orbassano-Turin, Italy.
giuseppe.saglio@unito.it


Dr. J. Cools
Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium
jan.cools@med.kuleuven.ac.be

Dr. D. Cilloni
Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, 10043 Orbassano-Turin, Italy.
daniela.cilloni@unito.it

Prof. C. Preudhomme
Laboratoire d'Hématologie A, Hôpital Calmette-CHU of Lille, France; Unité INSERM-U524-Lille
cpreudhomme@chru-lille.fr

Dr. A. Sureda
Clinical Hematology Division, Hospital de la Santa Creu i Sant Pau, St Antoni Maria Claret, 167, 08025 Barcelona, Spain.
asureda@hsp.santpau.es

Website

http://www.leukemia-net.org/

Studies

Italy
Imatinib in HES (Principal investigator: Prof. G. Martinelli, Bologna, see above)
Germany
Evaluation of the efficacy, safety and tolerability of imatinib mesylate (Glivec ) in patients with idiopathic hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL) and systemic mastocytosis with eosinophilia (SME). (Phase II).
(Principal investigator: PD Dr. A. Reiter, Mannheim, see above)

UK
Contact person: Prof. J. Apperley, London, see above


(for shortprotocols, see studies)

Contact persons

See above

Diagnostic Labs

Prof. Dr. N.C.P. Cross
Wessex Regional Cytogenetics Centre, Salisbury, United Kingdom.
ncpc@soton.ac.uk

PD Dr. A. Reiter
III. Medizinische Universitätsklinik, Klinikum Mannheim der Universität Heidelberg, Wiesbadener Str. 7-11, 68305 Mannheim, Germany
andreas.reiter@med3.ma.uni-heidelberg.de

Prof. Dr. Saglio
Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, 10043 Turin, Italy.
saglio@csi.it

Dr. J. Cools
Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium
jan.cools@med.kuleuven.ac.be

Prof. Dr. C. Preudhomme
Laboratoire d'Hématologie A, Hôpital Calmette-CHU of Lille, France; Unité INSERM-U524-Lille
cpreudhomme@chru-lille.fr

 

Print this Document   Sitemap   Contact  
EUTOS
EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe More ...


 
top